Research & Development



  衛青巡視扶荔宮大營的時候,看了雲瑯的設計圖紙沉默了良久,然後就帶著圖紙去犬台宮見皇帝。   雲瑯在屋子里來回踱步,半晌才道︰“陛下之所以要封禪泰山,是不是就是為了明年開春的征伐?”亚洲领先的青青草91自拍视频网站   雲瑯以為扶荔宮的城防工事不夠強大,他想加高城牆,加寬壕溝,手里頭有一萬多吃飽喝足的精壯男子,如果只讓他們在校場上砸地面那就太虧了。超碰福利久久精品视频久草在线观看   衛青搖頭道︰“很難,雲瑯素來有敝帚自珍的習慣,陛下只要看看他門下的幾位弟子就知曉了。張安世乃是張湯臨終托付的人,也未能在雲氏學堂中登堂入室,遑論其它了。”   果然,宋喬,甦稚回來的時候,臉上的寒霜就消褪了很多,尤其是甦稚笑的牙齒都露出來了。大香蕉电影   董仲舒焦急的道︰“霍氏長子如今已然八歲了……”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo